The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 01, 2016

Filed:

Oct. 21, 2014
Applicant:

Wyeth Llc, New York, NY (US);

Inventors:

William P. Hausdorff, Woluwe-Saint-Lambert, BE;

George Rainer Siber, New York, NY (US);

Peter R. Paradiso, Valley Forge, PA (US);

A. Krishna Prasad, Chapel Hill, NC (US);

Assignee:

Wyeth LLC, New York, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 39/09 (2006.01); A61K 39/385 (2006.01);
U.S. Cl.
CPC ...
A61K 39/092 (2013.01); A61K 39/385 (2013.01); A61K 2039/6031 (2013.01); A61K 2039/6037 (2013.01);
Abstract

An immunogenic composition having 13 distinct polysaccharide-protein conjugates and optionally, an aluminum-based adjuvant, is described. Each conjugate contains a capsular polysaccharide prepared from a different serotype of(1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F) conjugated to a carrier protein. The immunogenic composition, formulated as a vaccine, increases coverage against pneumococcal disease in infants and young children globally, and provides coverage for serotypes 6A and 19A that is not dependent on the limitations of serogroup cross-protection. Also described is a method for making an immunogenic conjugate comprisingserotype 1 polysaccharide covalently linked to a carrier protein, the method including partial de-O-acetylation of the polysaccharide by mild hydrolysis in an alkaline pH buffer.


Find Patent Forward Citations

Loading…